Produkty 80418-25-3

CAS 80418-25-3 występuje w naszej ofercie pod nazwami: 20(S)–NotoginsenosideR2, Notoginsenoside R2/ 99.37% (existing batch purity), Notoginsenoside R2 99%, (2S,3R,4S,5R)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol, 99.92% ,, 99.92% ,, Notoginsenoside R2 (Standard). Oferty producentów: GLPBio, TargetMol, Ambeed, Chemat, MedChemExpress. Dostępne opakowania: 20mg, 10mg, 25mg, 50mg, 5mg, 1mg, Get quote, 5 mg.

20(S)–NotoginsenosideR2
GLPBio
  • opakowanie: 20mg
  • Warianty: 1
od 2155,65
Zobacz produkt
Notoginsenoside R2/ 99.37% (existing batch purity)
TargetMol
  • opakowanie: 10mg
  • Warianty: 1
od 831,11
Zobacz produkt
Notoginsenoside R2 99%
Ambeed
  • opakowanie: 10mg, 25mg, 50mg
  • Warianty: 3
od 359,25
Zobacz produkt
(2S,3R,4S,5R)-2-(((2R,3R,4S,5S,6R)-2-(((3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-Dihydroxy-17-((S)-2-hydroxy-6-methylhept-5-en-2-yl)-4,4,8,10,14-pentamethylhexadecahydro-1H-cyclopenta[a]phenanthren-6-yl)oxy)-4,5-dihydroxy-6-(hydroxymethyl)tetrahydro-2H-pyran-3-yl)oxy)tetrahydro-2H-pyran-3,4,5-triol, 99.92% ,, 99.92% ,
Chemat
  • opakowanie: 5mg, 10mg, 25mg, 50mg
  • Warianty: 5
od 256,40
Zobacz produkt
Notoginsenoside R2 (Standard)
MedChemExpress
  • opakowanie: Get quote
  • Warianty: 1
Zobacz produkt
Notoginsenoside R2, 98.78%
MedChemExpress
  • opakowanie: 5 mg, 1 mg, 10 mg
  • Warianty: 3
od 361,49
Zobacz produkt
Wzór strukturalny: {0} (CAS {1})

(2S,3R,4S,5R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol (CAS 80418-25-3) to związek chemiczny o wzorze sumarycznym C41H70O13 i masie molowej 771.0 g/mol. Nazwa systematyczna IUPAC: (2S,3R,4S,5R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol. InChIKey: FNIRVWPHRMMRQI-PGOMJGFXSA-N.

Dane identyfikacyjne
Wzór sumarycznyC41H70O13
Masa molowa771.0 g/mol
Nazwa IUPAC(2S,3R,4S,5R)-2-[(2R,3R,4S,5S,6R)-2-[[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,12-dihydroxy-17-[(2S)-2-hydroxy-6-methylhept-5-en-2-yl]-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-6-yl]oxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]oxyoxane-3,4,5-triol
InChIKeyFNIRVWPHRMMRQI-PGOMJGFXSA-N
SMILESCC(=CCC[C@@](C)([C@H]1CC[C@@]2([C@@H]1[C@@H](C[C@H]3[C@]2(C[C@@H]([C@@H]4[C@@]3(CC[C@@H](C4(C)C)O)C)O[C@H]5[C@@H]([C@H]([C@@H]([C@H](O5)CO)O)O)O[C@H]6[C@@H]([C@H]([C@@H](CO6)O)O)O)C)O)C)O)C

Dane obliczone przez PubChem (NCBI)

Synonimy: Notoginsenoside R2, 20(S)-Notoginsenoside R2, Ginsenoside Ng-R2, Notoginsenoside R2 (Standard), orb1221773, orb1300202, orb3140570
Izomery (ten sam wzór sumaryczny)
(2R,3S,4S,5R,6S)-2-[[(2R,3R,4R,5S)-3,4-dihydroxy-5-(hydroxymethyl)oxolan-2-yl]oxymethyl]-6-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxyoxane-3,4,5-triol C41H70O13
(2S,3R,4S,5S,6R)-2-[(2S)-6-methyl-2-[(3S,5R,6S,8R,9R,10R,12R,13R,14R,17S)-3,6,12-trihydroxy-4,4,8,10,14-pentamethyl-2,3,5,6,7,9,11,12,13,15,16,17-dodecahydro-1H-cyclopenta[a]phenanthren-17-yl]hept-5-en-2-yl]oxy-6-[[(2S,3R,4S,5S)-3,4,5-trihydroxyoxan-2-yl]oxymethyl]oxane-3,4,5-triol C41H70O13